Phase 3 Venous Thromboembolism study

Study Details

Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to the standard of care in children with acute venous thromboembolism (Bayer Einstein Junior)

Protocol Number

N/A

Phase

III

Therapeutic Area

Cardiovascular

Subject Types

With Medical Condition

Indication

Venous Thromboembolism

Principal Investigator

Dr Koh Pei Lin

Investigator Product / Device

Rivaroxaban

Sponsor

Bayer